MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Cash Flow Overview

Change in Cash
-$38,114K
Free Cash flow
-$21,696K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Equity-based compensation
    • Prepaid expenses and other curre...
    • Accrued expenses and other curre...
    • Others
Negative Cash Flow Breakdown
    • Net loss
    • Purchases of available-for-sale ...
    • Other non-current assets
    • Others

Cash Flow
2026-03-31
Net loss
-22,687
Equity-based compensation
1,318
Depreciation and amortization
73
Non-cash lease expense
-153
Accretion of discount on available-for-sale debt securities
816
Prepaid expenses and other current assets
-1,166
Other non-current assets
1,016
Accounts payable
-52
Accrued expenses and other current liabilities
434
Operating lease liabilities
-157
Net cash used in operating activities
-21,584
Purchases of available-for-sale debt securities
15,735
Purchases of property and equipment
112
Net cash used in investing activities
-15,847
Payment of offering costs
414
Principal payments on finance lease
46
Net cash used in financing activities
-460
Effect of foreign exchange rate changes on cash and cash equivalents
-223
Net decrease in cash and cash equivalents
-38,114
Cash and cash equivalents at beginning of period
87,974
Cash and cash equivalents at end of period
49,860
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Net decrease in cashand cash...-$38,114K Equity-based compensation$1,318K Prepaid expenses andother current assets-$1,166K Accrued expenses andother current...$434K Non-cash lease expense-$153K Depreciation andamortization$73K Net cash used inoperating activities-$21,584K Net cash used ininvesting activities-$15,847K Net cash used infinancing activities-$460K Effect of foreignexchange rate changes on...-$223K Canceled cashflow$3,144K Net loss-$22,687K Purchases ofavailable-for-sale debt securities$15,735K Purchases of property andequipment$112K Payment of offeringcosts$414K Principal payments onfinance lease$46K Other non-currentassets$1,016K Accretion of discount onavailable-for-sale debt securities$816K Operating leaseliabilities-$157K Accounts payable-$52K

Hemab Therapeutics Holdings, Inc. (COAG)

Hemab Therapeutics Holdings, Inc. (COAG)